Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -3.85 is 148% below its 5-year average of -1.55, near the low end of its 5-year range (-3.85–-0.01).
42.07% below its 12-month average of -2.71.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.84.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 17 comparable quarters.
EARNINGS PER SHARE (EPS)
-3.85
EARNINGS PER SHARE (EPS) AVG TTM
-2.71
EARNINGS PER SHARE (EPS) AVG 3Y
-1.96
EARNINGS PER SHARE (EPS) AVG 5Y
-1.55
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
-42.07%
CURRENT VS 3Y AVG
-96.18%
CURRENT VS 5Y AVG
-148.22%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
MoonLake Immunotherapeutics
Market Cap
$921.06M
Earnings Per Share (EPS)
-3.85
TTM Avg
-2.71
3Y Avg
-1.96
5Y Avg
-1.55
Market Cap
$923.53M
Earnings Per Share (EPS)
-1.76
TTM Avg
-1.29
3Y Avg
-1.36
5Y Avg
-1.36
Market Cap
$914.73M
Earnings Per Share (EPS)
0.72
TTM Avg
0.64
3Y Avg
0.54
5Y Avg
0.47
Market Cap
$929.83M
Earnings Per Share (EPS)
N/A
TTM Avg
-1.94
3Y Avg
-1.94
5Y Avg
-1.94
Market Cap
$934.79M
Earnings Per Share (EPS)
-3.37
TTM Avg
-2.60
3Y Avg
-2.33
5Y Avg
-2.16
Market Cap
$952.91M
Earnings Per Share (EPS)
-0.58
TTM Avg
-0.51
3Y Avg
-0.40
5Y Avg
-0.46
Market Cap
$953.81M
Earnings Per Share (EPS)
-1.05
TTM Avg
-1.23
3Y Avg
-0.94
5Y Avg
-0.94
Market Cap
$887.99M
Earnings Per Share (EPS)
-0.64
TTM Avg
-0.60
3Y Avg
-0.67
5Y Avg
-0.65
Market Cap
$887.50M
Earnings Per Share (EPS)
0.77
TTM Avg
-0.09
3Y Avg
-1.31
5Y Avg
-0.73
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MoonLake Immunotherapeutics (MLTX) | $921.06M | -3.85 | -2.71 | -1.96 | -1.55 |
| CeriBell, Inc. (CBLL)vs › | $923.53M | -1.76 | -1.29 | -1.36 | -1.36 |
| HealthStream, Inc. (HSTM)vs › | $914.73M | 0.72 | 0.64 | 0.54 | 0.47 |
| Seaport Therapeutics, Inc. Common Stock (SPTX)vs › | $929.83M | N/A | -1.94 | -1.94 | -1.94 |
| Kura Oncology, Inc. (KURA)vs › | $934.79M | -3.37 | -2.60 | -2.33 | -2.16 |
| Savara Inc. (SVRA)vs › | $952.91M | -0.58 | -0.51 | -0.40 | -0.46 |
| Aktis Oncology, Inc. (AKTS)vs › | $953.81M | -1.05 | -1.23 | -0.94 | -0.94 |
| Corvus Pharmaceuticals, Inc. (CRVS)vs › | $887.99M | -0.64 | -0.60 | -0.67 | -0.65 |
| Bioventus Inc. (BVS)vs › | $887.50M | 0.77 | -0.09 | -1.31 | -0.73 |
| Arbutus Biopharma Corp (ABUS)vs › | $884.97M | 0.78 | -0.28 | -0.36 | -0.51 |
Trailing EPS (TTM)
$-3.85
Forward EPS (Est.)
$-3.37
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -3.53 |
| 2024-12-31 | -1.89 |
| 2023-12-31 | -0.73 |
| 2022-12-31 | -1.70 |
| 2021-12-31 | -1.45 |
| 2020-12-31 | -0.01 |
